Cognition You are welcome. As I said as of now the next class of anti-cancer drugs approved by the FDA will be the selective immune-system recognition immunotherapy drugs that OncoSec and the Major Pharmas are currently working on. That is where one wants to invest.
Protein P53 can be explosive in doing too much and there is much to learn yet by the researchers. There is great promise but it is off in the future as to proven safe applications in humans.
News 
Market Data 
Discover 
AI
